Cargando…

A Hepatitis C Virus Infection Model with Time-Varying Drug Effectiveness: Solution and Analysis

Simple models of therapy for viral diseases such as hepatitis C virus (HCV) or human immunodeficiency virus assume that, once therapy is started, the drug has a constant effectiveness. More realistic models have assumed either that the drug effectiveness depends on the drug concentration or that the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conway, Jessica M., Perelson, Alan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125050/ https://www.ncbi.nlm.nih.gov/pubmed/25101902 http://dx.doi.org/10.1371/journal.pcbi.1003769

Ejemplares similares

A New Age-Structured Multiscale Model of the Hepatitis C Virus Life-Cycle During Infection and Therapy With Direct-Acting Antiviral Agents
por: Quintela, Barbara de M., et al.
Publicado: (2018)

Mathematical modeling of hepatitis C RNA replication, exosome secretion and virus release
por: Zitzmann, Carolin, et al.
Publicado: (2020)

Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study
por: Canini, Laetitia, et al.
Publicado: (2014)

Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model
por: Rong, Libin, et al.
Publicado: (2013)

Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
por: Conway, Jessica M., et al.
Publicado: (2019)

Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence
por: Ke, Ruian, et al.
Publicado: (2018)

Residual Viremia in Treated HIV(+) Individuals
por: Conway, Jessica M., et al.
Publicado: (2016)

Kinetics of Acute Hepatitis B Virus Infection in Humans
por: Whalley, Simon A., et al.
Publicado: (2001)

Antibody Responses during Hepatitis B Viral Infection
por: Ciupe, Stanca M., et al.
Publicado: (2014)

Unified model of short- and long-term HIV viral rebound for clinical trial planning
por: Conway, Jessica M., et al.
Publicado: (2021)

Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance
por: Shekhtman, Louis, et al.
Publicado: (2021)

C (1)-Almost Periodic Solutions of BAM Neural Networks with Time-Varying Delays on Time Scales
por: Li, Yongkun, et al.
Publicado: (2015)

Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population
por: Immonen, Taina T., et al.
Publicado: (2015)

Quantifying the Diversification of Hepatitis C Virus (HCV) during Primary Infection: Estimates of the In Vivo Mutation Rate
por: Ribeiro, Ruy M., et al.
Publicado: (2012)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Modeling the within-host dynamics of HIV infection
por: Perelson, Alan S, et al.
Publicado: (2013)

Modeling Within-Host Dynamics of Influenza Virus Infection Including Immune Responses
por: Pawelek, Kasia A., et al.
Publicado: (2012)

Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy
por: Rong, Libin, et al.
Publicado: (2009)

Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification
por: Li, Hui, et al.
Publicado: (2015)

In-house quantitative real-time PCR for the diagnosis of hepatitis B virus and hepatitis C virus infections
por: Zauli, Danielle Alves Gomes, et al.
Publicado: (2016)

Spatiotemporal Analysis of Hepatitis C Virus Infection
por: Shulla, Ana, et al.
Publicado: (2015)

Model of Care for Microelimination of Hepatitis C Virus Infection among People Who Inject Drugs
por: Foschi, Francesco Giuseppe, et al.
Publicado: (2021)

Estimating time since infection in early homogeneous HIV-1 samples using a poisson model
por: Giorgi, Elena E, et al.
Publicado: (2010)

Models of SIV rebound after treatment interruption that involve multiple reactivation events
por: van Dorp, Christiaan H., et al.
Publicado: (2020)

Animal Models to Study Hepatitis C Virus Infection
por: Burm, Rani, et al.
Publicado: (2018)

Suppression of hepatitis B virus through therapeutic activation of RIG-I and IRF3 signaling in hepatocytes
por: Lee, Sooyoung, et al.
Publicado: (2021)

Modeling the Effects of Morphine on Simian Immunodeficiency Virus Dynamics
por: Vaidya, Naveen K., et al.
Publicado: (2016)

Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China
por: Wang, Haiying, et al.
Publicado: (2018)

A Coupled Mathematical Model of the Intracellular Replication of Dengue Virus and the Host Cell Immune Response to Infection
por: Zitzmann, Carolin, et al.
Publicado: (2020)

Neurological and psychiatric effects of hepatitis C virus infection
por: Faccioli, Jessica, et al.
Publicado: (2021)

Hepatitis C Virus and Hepatitis B Virus Co-Infection
por: Shih, Yi-Fen, et al.
Publicado: (2020)

Repeated spontaneous clearance of hepatitis C virus infection in the setting of long-term non-progression of HIV infection
por: Kerkerian, Genevieve, et al.
Publicado: (2017)

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants
por: Cooper, Curtis L., et al.
Publicado: (2020)

MBL2 and Hepatitis C Virus Infection among Injection Drug Users
por: Brown, Elizabeth E, et al.
Publicado: (2008)

Chimeric Mouse Model for the Infection of Hepatitis B and C Viruses
por: Tesfaye, Abeba, et al.
Publicado: (2013)

Antiviral drugs against hepatitis C virus
por: Rehman, Sidra, et al.
Publicado: (2011)

Anti-hepatitis C virus drugs and kidney
por: Carrier, Paul, et al.
Publicado: (2016)

Hepatitis C Virus and Antiviral Drug Resistance
por: Kim, Seungtaek, et al.
Publicado: (2016)

Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection
por: Zhou, Yan, et al.
Publicado: (2012)

Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection
por: Hsieh, Meng-Hsuan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v3hjj1er6fiecgtbdphusdk8g6